Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice

Autor: Elizabeth Berry-Kravis, Sara Abozeid, Crystal Hervey, M. Shahriar Salamat, Brian C. Ray, James S. Malter, Corinna Burger, Cara J. Westmark, Pamela R. Westmark, Kenneth J. O’Riordan, Kelsey M. Stein, Levi A. Stodola, Michael Tranfaglia
Rok vydání: 2011
Předmět:
Male
Dendritic spine
Mouse
lcsh:Medicine
Hippocampal formation
Developmental and Pediatric Neurology
Receptors
Metabotropic Glutamate

Pediatrics
Amyloid beta-Protein Precursor
Fragile X Mental Retardation Protein
Mice
Behavioral Neuroscience
0302 clinical medicine
Neurobiology of Disease and Regeneration
lcsh:Science
Receptor
Mice
Knockout

Neurons
0303 health sciences
Multidisciplinary
Neuronal Morphology
Cognitive Neurology
Animal Models
Fragile X syndrome
Phenotype
Neurology
Medicine
Female
Research Article
medicine.medical_specialty
Down syndrome
congenital
hereditary
and neonatal diseases and abnormalities

Drugs and Devices
Drug Research and Development
Dendritic Spines
Down-Regulation
Biology
Signaling Pathways
03 medical and health sciences
Model Organisms
Internal medicine
medicine
Animals
Allele
030304 developmental biology
Brain Chemistry
Amyloid beta-Peptides
lcsh:R
Genetic Therapy
medicine.disease
FMR1
Peptide Fragments
Endocrinology
Metabotropic glutamate receptor
Fragile X Syndrome
Cellular Neuroscience
Immunology
lcsh:Q
Molecular Neuroscience
030217 neurology & neurosurgery
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Vol 6, Iss 10, p e26549 (2011)
ISSN: 1932-6203
Popis: Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading known genetic cause of autism. Fragile X mental retardation protein (FMRP), which is absent or expressed at substantially reduced levels in FXS, binds to and controls the postsynaptic translation of amyloid β-protein precursor (AβPP) mRNA. Cleavage of AβPP can produce β-amyloid (Aβ), a 39-43 amino acid peptide mis-expressed in Alzheimer's disease (AD) and Down syndrome (DS). Aβ is over-expressed in the brain of Fmr1(KO) mice, suggesting a pathogenic role in FXS. To determine if genetic reduction of AβPP/Aβ rescues characteristic FXS phenotypes, we assessed audiogenic seizures (AGS), anxiety, the ratio of mature versus immature dendritic spines and metabotropic glutamate receptor (mGluR)-mediated long-term depression (LTD) in Fmr1(KO) mice after removal of one App allele. All of these phenotypes were partially or completely reverted to normal. Plasma Aβ(1-42) was significantly reduced in full-mutation FXS males compared to age-matched controls while cortical and hippocampal levels were somewhat increased, suggesting that Aβ is sequestered in the brain. Evolving therapies directed at reducing Aβ in AD may be applicable to FXS and Aβ may serve as a plasma-based biomarker to facilitate disease diagnosis or assess therapeutic efficacy.
Databáze: OpenAIRE